Related Experiment Video
Updated: Oct 12, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents
Abstract:
The relationship of DDT myoclonus and antimyoclonic agents to the concentration of cGMP in the cerebellum was investigated. Intragastric administration of 600 mg/kg DDT increased mouse cerebellar cGMP levels about 4 fold. Antimyoclonic agents, such as L-5HTP plus fluoxetine, clonazepam, phenoxybenzamine, prostaglandin E2 and harmaline, all counteracted the elevation of cerebellar cGMP induced by DDT. Cinnanserin, a 5-HT receptor blocker, did not counteract the reduction of cerebellar cGMP produced by L-5HTP plus fluoxetine, clonazepam, and phenoxybenzamine, although cinnanserin abolished the antimyoclonic actions of these agents. Destruction of the inferior olive-climbing fiber pathway by 3-acetylpyridine in rats did not prevent the elevation of cerebellar cGMP levels by DDT. L-5HTP, clonazepam and phenoxybenzamine still significantly counteracted DDT-induced elevation of cerebellar cGMP levels in the inferior olive lesioned rats, although these agents no longer had any antimyoclonic action in these animals. These data indicate that 1) DDT-induced elevation of cerebellar cGMP and DDT-induced myoclonus are not related, and 2) antimyoclonic agents counteract DDT-induced elevation of cerebellar cGMP levels via pathways other than the olivo-cerebellar tract.
Insights
DDT exposure increases cerebellar cGMP levels in mice. Antimyoclonic drugs counteract this increase, but not through the olivo-cerebellar pathway, suggesting separate mechanisms for myoclonus and cGMP changes.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- DDT (dichlorodiphenyltrichloroethane) is an insecticide known to cause neurological effects, including myoclonus.
- Cyclic guanosine monophosphate (cGMP) is a key second messenger in the central nervous system, particularly in cerebellar function.
- The precise mechanisms linking DDT-induced myoclonus, cerebellar cGMP levels, and the action of antimyoclonic agents remain unclear.
Purpose of the Study:
- To investigate the relationship between DDT-induced myoclonus and cerebellar cGMP concentrations.
- To determine if antimyoclonic agents counteract DDT-induced elevations in cerebellar cGMP.
- To elucidate the pathways involved in the antimyoclonic effects of these agents on cerebellar cGMP.
Main Methods:
- Mice were administered DDT (600 mg/kg) intragastrically to measure cerebellar cGMP levels.
- The effects of various antimyoclonic agents (L-5HTP plus fluoxetine, clonazepam, phenoxybenzamine, prostaglandin E2, harmaline) on DDT-induced cGMP elevation were assessed.
- The role of the inferior olive-climbing fiber pathway was examined in rats with lesions induced by 3-acetylpyridine.
Main Results:
- DDT administration significantly increased cerebellar cGMP levels approximately fourfold.
- Several antimyoclonic agents successfully counteracted the DDT-induced rise in cerebellar cGMP.
- Cinnanserin, a 5-HT receptor blocker, blocked the antimyoclonic actions but not the cGMP modulation by certain agents.
- Lesioning the inferior olive-climbing fiber pathway did not prevent DDT-induced cGMP elevation, and antimyoclonic agents still affected cGMP levels in these lesioned animals, despite losing their antimyoclonic effect.
Conclusions:
- DDT-induced elevation of cerebellar cGMP is dissociated from DDT-induced myoclonus.
- Antimyoclonic agents counteract DDT-induced cerebellar cGMP increases through mechanisms independent of the olivo-cerebellar tract.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
09:00Investigating The Network-Wide Mechanisms of Pallidal Deep Brain Stimulation Using High-Density Microelectrode Arrays
Published on: June 16, 2026
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Tetanus
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll